Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. MicroTech Medical (Hangzhou) Co's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$93.8 Mil.
MicroTech Medical (Hangzhou) Co's average Total Assets over the quarter that ended in Dec. 2025 was HK$2,482.7 Mil. Therefore, MicroTech Medical (Hangzhou) Co's annualized ROA % for the quarter that ended in Dec. 2025 was 3.78%.
HKSE:02235'
s ROA % Range Over the Past 10 Years
Min: -29.69 Med: -3.13 Max: 1.83
Current: 1.83
During the past 7 years, MicroTech Medical (Hangzhou) Co's highest ROA % was 1.83%. The lowest was -29.69%. And the median was -3.13%.
HKSE:02235's ROA % is ranked better than 54.51% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.74
vs HKSE:02235: 1.83
MicroTech Medical (Hangzhou) Co (HKSE:02235) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
MicroTech Medical (Hangzhou) Co ROA % Related Terms
MicroTech Medical (Hangzhou) Co ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroTech Medical (Hangzhou) Co ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's ROA % distribution charts can be found below:
* The bar in red indicates where MicroTech Medical (Hangzhou) Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
MicroTech Medical (Hangzhou) Co (HKSE:02235) has a ROA % of 3.78% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on MicroTech Medical (Hangzhou) Co and its competitors. According to the industry distribution chart, MicroTech Medical (Hangzhou) Co ranks #388 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 45.5%.
Is MicroTech Medical (Hangzhou) Co's ROA % too high?
MicroTech Medical (Hangzhou) Co's current ROA % is 3.78%. The Medical Devices & Instruments industry median ROA % is 0.74. MicroTech Medical (Hangzhou) Co's value of 3.78% is 410.8% above this industry median. Based on the distribution chart, MicroTech Medical (Hangzhou) Co ranks #388 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MicroTech Medical (Hangzhou) Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroTech Medical (Hangzhou) Co's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroTech Medical (Hangzhou) Co ranks #388 out of 853 companies for ROA %. This puts MicroTech Medical (Hangzhou) Co in the upper half of its industry. The industry median ROA % is 0.74. MicroTech Medical (Hangzhou) Co's value of 3.78% is 410.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.74, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroTech Medical (Hangzhou) Co's current ROA % of 3.78% is 410.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on MicroTech Medical (Hangzhou) Co and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroTech Medical (Hangzhou) Co's current ROA % is 3.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroTech Medical (Hangzhou) Co stock overvalued right now?
Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co (HKSE:02235) is currently considered Possible Value Trap. The stock's GF Value™ is HK$15.94, compared to a current price of HK$7.26 — trading 54.5% below its estimated fair value. The current ROA % is 3.78% and 410.8% above the Medical Devices & Instruments industry median of 0.74. MicroTech Medical (Hangzhou) Co's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For MicroTech Medical (Hangzhou) Co (HKSE:02235), the current ROA % is 3.78% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroTech Medical (Hangzhou) Co (HKSE:02235) Overvalued in 2026?
Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co stock appears to be undervalued.
The current stock price of HK$7.26 is trading 54.5% below its estimated GF Value™ of HK$15.94.
GuruFocus considers MicroTech Medical (Hangzhou) Co to be Possible Value Trap.
Key valuation signals for HKSE:02235:
ROA %: 3.78%
GF Value™: HK$15.94 vs. price of HK$7.26 (54.5% below fair value)
Industry Position: 410.8% above the Medical Devices & Instruments median (#388 of 853)
No single metric tells the full story. See the HKSE:02235 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroTech Medical (Hangzhou) Co Ltd is focused on diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve the diabetes management in China and globally. The Group operates in a large and fast-growing diabetes monitoring, treatment and management market in China and globally with unmet clinical needs. The company derives a majority of its revenue from China.
80GF Score
Get the complete analysis for HKSE:02235
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02235 has been successfully added to your 
